Erratum: Discovery of (2 R)-2-(3-{3-[(4-methoxyphenyl)carbonyl]-2-methyl-6- (trifluoromethoxy)-1 H -indol-1-yl}phenoxy)butanoic acid (MK-0533): A novel selective peroxisome proliferator-activated receptor γ modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume

John J. Acton, Taro E. Akiyama, Ching H. Chang, Lawrence Colwell, Sheryl Debenham, Thomas Doebber, Monica Einstein, Kun Liu, Margaret E. McCann, David E. Moller, Eric S. Muise, Yejun Tan, John R. Thompson, Kenny K. Wong, Margaret Wu, Libo Xu, Peter T. Meinke, Joel P. Berger, Harold B. Wood

Research output: Contribution to journalComment/debate

4 Scopus citations
Original languageEnglish
Pages (from-to)9368
Number of pages1
JournalJournal of Medicinal Chemistry
Volume56
Issue number22
DOIs
StatePublished - 27 Nov 2013

Cite this